Value of morphometry as an independent prognostic factor in renal cell carcinoma. 1995

J L Ruiz, and M Hernández, and J Martínez, and C Vera, and J F Jimenez-Cruz
Department of Urology, La Fé Hospital, Valencia, Spain.

Nuclear morphometry was performed in 159 adenocarcinomas of the kidney. The mean and SD of the following nuclear parameters were calculated: area, perimeter, major axis, minor axis and a shape factor. Median survival, including all stages, was 72 months and cumulative survival at 5, 10 and 15 years of 50, 42 and 33%, respectively. Values of morphometric parameters, except for shape factor, tend to increase in proportion to stage. Nuclear area was the best parameter to predict the variability in survival time. The Cox regression model was performed for each stage, and the relationship with length of survival time was studied. For stage T1-2 N0 M0, nuclear area was the only variable chosen as an independent significant predictor of outcome. For the rest of the stages, no variables were selected as predictors at any significant level.

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D003627 Data Interpretation, Statistical Application of statistical procedures to analyze specific observed or assumed facts from a particular study. Data Analysis, Statistical,Data Interpretations, Statistical,Interpretation, Statistical Data,Statistical Data Analysis,Statistical Data Interpretation,Analyses, Statistical Data,Analysis, Statistical Data,Data Analyses, Statistical,Interpretations, Statistical Data,Statistical Data Analyses,Statistical Data Interpretations
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

J L Ruiz, and M Hernández, and J Martínez, and C Vera, and J F Jimenez-Cruz
December 1986, Cancer,
J L Ruiz, and M Hernández, and J Martínez, and C Vera, and J F Jimenez-Cruz
January 1991, Acta oncologica (Stockholm, Sweden),
J L Ruiz, and M Hernández, and J Martínez, and C Vera, and J F Jimenez-Cruz
October 2016, Urology,
J L Ruiz, and M Hernández, and J Martínez, and C Vera, and J F Jimenez-Cruz
January 1999, Histology and histopathology,
J L Ruiz, and M Hernández, and J Martínez, and C Vera, and J F Jimenez-Cruz
September 2009, Medicina clinica,
J L Ruiz, and M Hernández, and J Martínez, and C Vera, and J F Jimenez-Cruz
September 2006, Japanese journal of clinical oncology,
J L Ruiz, and M Hernández, and J Martínez, and C Vera, and J F Jimenez-Cruz
March 2019, Biomarkers in medicine,
J L Ruiz, and M Hernández, and J Martínez, and C Vera, and J F Jimenez-Cruz
September 2022, Translational oncology,
J L Ruiz, and M Hernández, and J Martínez, and C Vera, and J F Jimenez-Cruz
June 2017, Urologic oncology,
J L Ruiz, and M Hernández, and J Martínez, and C Vera, and J F Jimenez-Cruz
December 2012, BJU international,
Copied contents to your clipboard!